Institutional Ownership Harvard Bioscience Inc (HBIO)
This table provides information about the institutional ownership of Harvard Bioscience Inc (HBIO). We have compiled data on the 76 institutions that hold shares in the stock, with a total of 22.6 Million shares, which have been reported (via 13F filing form) to have a value of $9.93 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|
Clari Vest Asset Management LLC
San Diego, CA |
Nov 12, 2024 Q3 2024 |
114,271
shares
|
$50,279
0.03% of portfolio
|
Q2 2024
Added 2.91%
|
|
|
Williams & Novak, LLC
Westlake Village, CA |
Jul 24, 2025 Q2 2025 |
106,570
shares
|
$46,890
0.04% of portfolio
|
Q2 2025
Added 37.03%
|
|
|
Mario Gabelli
Gamco Investors, Inc. Et Al | Rye, Ny
|
Aug 13, 2025 Q2 2025 |
77,000
shares
|
$33,880
0.0% of portfolio
|
Q2 2025
Reduced 9.41%
|
|
|
Jane Street Group, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
70,736
shares
|
$31,123
0.0% of portfolio
|
Q2 2025
Added 491.88%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Aug 14, 2025 Q2 2025 |
51,195
shares
|
$22,525
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Gabelli Funds LLC
Rye, NY |
Aug 13, 2025 Q2 2025 |
50,000
shares
|
$22,000
0.0% of portfolio
|
Q2 2025
Reduced 23.08%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Aug 14, 2025 Q2 2025 |
46,851
shares
|
$20,614
0.0% of portfolio
|
Q2 2025
Reduced 65.44%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
Aug 14, 2025 Q2 2025 |
45,706
shares
|
$20,110
0.0% of portfolio
|
Q2 2025
Added 100.64%
|
|
|
Hrt Financial LP
New York, NY |
Aug 14, 2025 Q2 2025 |
41,464
shares
|
$18,244
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
40,943
shares
|
$18,014
0.0% of portfolio
|
Q1 2025
Reduced 63.96%
|
|
|
Abel Hall, LLC
Baton Rouge, LA |
Jul 23, 2025 Q2 2025 |
37,334
shares
|
$16,426
0.01% of portfolio
|
Q2 2025
New holding
|
|
|
Callan Family Office, LLC
Radnor, PA |
Jul 24, 2025 Q2 2025 |
29,844
shares
|
$13,131
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
29,556
shares
|
$13,004
0.0% of portfolio
|
Q2 2025
Reduced 65.11%
|
|
|
Greenwood Capital Associates LLC
Greenwood, SC |
Jul 21, 2025 Q2 2025 |
27,754
shares
|
$12,211
0.0% of portfolio
|
Q2 2025
Reduced 2.58%
|
|
|
Point72 Asia (Singapore) Pte. Ltd.
Singapore, U0 |
Aug 14, 2025 Q2 2025 |
27,238
shares
|
$11,984
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Virtu Financial LLC
New York, NY |
Aug 12, 2025 Q2 2025 |
26,544
shares
|
$11,679
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Brighton Jones LLC
|
Jul 31, 2025 Q2 2025 |
25,092
shares
|
$11,040
0.0% of portfolio
|
Q2 2025
Added 0.37%
|
|
|
Sg Americas Securities, LLC
|
Aug 08, 2025 Q2 2025 |
21,503
shares
|
$9,461
0.0% of portfolio
|
Q2 2025
Added 82.99%
|
|
|
Y Intercept (Hong Kong) LTD
|
Aug 01, 2025 Q2 2025 |
16,940
shares
|
$7,453
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Tower Research Capital LLC (Trc)
New York, NY |
Aug 14, 2025 Q2 2025 |
15,618
shares
|
$6,871
0.0% of portfolio
|
Q2 2025
Added 3.15%
|
|
|
Camden Capital, LLC
|
Aug 14, 2025 Q2 2025 |
14,712
shares
|
$6,473
0.0% of portfolio
|
Q3 2024
Added 0.08%
|
|
|
Legato Capital Management LLC
|
Aug 14, 2025 Q2 2025 |
14,005
shares
|
$6,162
0.0% of portfolio
|
Q2 2025
Reduced 4.7%
|
|
|
Citigroup Inc
|
Aug 11, 2025 Q2 2025 |
13,833
shares
|
$6,086
0.0% of portfolio
|
Q2 2025
Reduced 52.95%
|
|
|
Ethic Inc.
New York, NY |
Jul 30, 2025 Q2 2025 |
13,009
shares
|
$5,723
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Aug 14, 2025 Q2 2025 |
12,500
shares
|
$5,500
0.0% of portfolio
|
Q2 2025
Reduced 86.04%
|